Home
Conditions
Neoplasms, Ductal, Lobular, and Medullary

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

477 public trials 97 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Completed

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

NCT00256217

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations: Chao Family Comprehensive Cancer Center Orange, California, United States

View Trial Details

Completed

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

NCT00704730

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations: University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States

TGEN Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Burbank, California, United States

View all 113 locations

View Trial Details

Completed

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

NCT03072160

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

NCT02682693

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +18 more
Locations: Charité Campus Mitte Berlin, Germany

View Trial Details

Completed

Intraoperative Imaging of Breast Cancer With Indocyanine Green

NCT01796041

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +13 more
Locations: Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

NCT00514046

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +22 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

NCT00290745

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy

NCT02576106

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations: Centre Léon Bérard Lyon, France

View Trial Details

Completed

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

NCT00496808

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +12 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

NCT02658214

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
Locations: Research Site Chūōku, Japan

Research Site Kashiwa, Japan

Research Site Seoul, South Korea

Research Site Seoul, South Korea

View Trial Details

Neoplasms, Ductal, Lobular, and Medullary

Neoplasms, Ductal, Lobular, and Medullary trial results

Related conditions